Sign inGet started

Stuckley Carol

Insider CIK 1863298 · EPZM Director · CNTA Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CNTA Centessa Pharmaceuticals p D To issuer deriv2026-06-242026-06-2440,000— $00SEC↗
CNTA Centessa Pharmaceuticals p D To issuer deriv2026-06-242026-06-2448,000— $00SEC↗
CNTA Centessa Pharmaceuticals p D To issuer deriv2026-06-242026-06-2448,000— $00SEC↗
CNTA Centessa Pharmaceuticals p D To issuer deriv2026-06-242026-06-2448,000— $00SEC↗
CNTA Centessa Pharmaceuticals p D To issuer deriv2026-06-242026-06-24208,474— $00SEC↗
CNTA Centessa Pharmaceuticals p A Award deriv2025-06-202025-06-2440,000— $040,000SEC↗
CNTA Centessa Pharmaceuticals p A Award deriv2024-06-252024-06-2748,000— $048,000SEC↗
CNTA Centessa Pharmaceuticals p A Award deriv2023-06-222023-06-2348,000— $048,000SEC↗
EPZM Epizyme, Inc. D To issuer2022-08-122022-08-1625,696— $00SEC↗
CNTA Centessa Pharmaceuticals p A Award deriv2022-06-302022-07-0548,000— $048,000SEC↗
EPZM Epizyme, Inc. A Award deriv2022-05-172022-05-1941,006— $041,006SEC↗
EPZM Epizyme, Inc. A Award2022-05-172022-05-198,994— $025,696SEC↗
EPZM Epizyme, Inc. A Award deriv2021-11-162021-11-1883,298— $083,298SEC↗
EPZM Epizyme, Inc. A Award2021-11-162021-11-1816,702— $016,702SEC↗